These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36967933)

  • 1. Comparison between olfactory training and curcumin therapy in improving olfactory dysfunction in patients with chronic kidney disease.
    Malekmakan L; Doostkam A; Iravani K; Roozbeh J; Sookhaklari MA; Maryam Pakfetrat
    Heliyon; 2023 Mar; 9(3):e14478. PubMed ID: 36967933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory dysfunction in cystic fibrosis: Impact of CFTR modulator therapy.
    Beswick DM; Humphries SM; Balkissoon CD; Strand M; Vladar EK; Ramakrishnan VR; Taylor-Cousar JL
    J Cyst Fibros; 2022 Mar; 21(2):e141-e147. PubMed ID: 34598881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability and validity of the Korean version of the Questionnaire of Olfactory Disorders.
    Choi WR; Jeong HY; Kim JH
    Int Forum Allergy Rhinol; 2018 Dec; 8(12):1481-1485. PubMed ID: 30039926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive significance of the questionnaire of olfactory disorders-negative statements for olfactory loss in patients with chronic rhinosinusitis.
    Yuan F; Wu D; Wei Y
    Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5253-5262. PubMed ID: 35718822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory-related Quality of Life Adjustments in Smell Loss during the Coronavirus-19 Pandemic.
    Liu DT; Prem B; Besser G; Renner B; Mueller CA
    Am J Rhinol Allergy; 2022 Mar; 36(2):253-260. PubMed ID: 34704454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features of Olfactory Dysfunction in COVID-19 Patients.
    Seo MY; Choi WS; Lee SH
    J Korean Med Sci; 2021 Jun; 36(22):e161. PubMed ID: 34100564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and validity of a brief version of the Questionnaire of Olfactory Disorders (brief QOD) in patients with olfactory dysfunction.
    Zou L; Haehner A; Menzel S; Gunder N; Hummel T
    Rhinology; 2022 Feb; 60(1):56-62. PubMed ID: 34874020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-perceived Taste and Flavor Perception: Associations With Quality of Life in Patients With Olfactory Loss.
    Liu DT; Besser G; Prem B; Sharma G; Speth MM; Sedaghat AR; Mueller CA
    Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1330-1336. PubMed ID: 33048605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfactory-specific quality of life outcomes after endoscopic sinus surgery.
    Soler ZM; Smith TL; Alt JA; Ramakrishnan VR; Mace JC; Schlosser RJ
    Int Forum Allergy Rhinol; 2016 Apr; 6(4):407-13. PubMed ID: 26678351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trend of Olfactory and Gustatory Dysfunction in COVID-19 Patients in a Quarantine Facility.
    Seo MY; Seok H; Hwang SJ; Choi HK; Jeon JH; Sohn JW; Park DW; Lee SH; Choi WS
    J Korean Med Sci; 2020 Oct; 35(41):e375. PubMed ID: 33107232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olfactory Identification among Various Subtypes of Parkinson Disease.
    Jalali MM; Roudbary SA; Gerami H; Soleimani R; Ebrahimi SM
    Eur Neurol; 2019; 81(3-4):167-173. PubMed ID: 31291631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability and validity of the Polish version of the Questionnaire of Olfactory Disorders.
    Tuz-Hrycyna N; Rzepakowska A; Niemczyk K
    Laryngoscope Investig Otolaryngol; 2023 Aug; 8(4):799-807. PubMed ID: 37621288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1: Study Protocol for a Multicenter Clinical Trial.
    Weir MA; Walsh M; Cuerden MS; Sontrop JM; Chambers LC; Garg AX
    Can J Kidney Health Dis; 2018; 5():2054358118813088. PubMed ID: 30619615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mometasone furoate nasal spray in the treatment of patients with COVID-19 olfactory dysfunction: A randomized, double blind clinical trial.
    Kasiri H; Rouhani N; Salehifar E; Ghazaeian M; Fallah S
    Int Immunopharmacol; 2021 Sep; 98():107871. PubMed ID: 34147912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Treat Post-COVID-19 Olfactory Impairment: A Multi-Center Double-Blinded Randomized Placebo- Controlled Clinical Trial.
    Di Stadio A; D'Ascanio L; Vaira LA; Cantone E; De Luca P; Cingolani C; Motta G; De Riu G; Vitelli F; Spriano G; De Vincentiis M; Camaioni A; La Mantia I; Ferreli F; Brenner MJ
    Curr Neuropharmacol; 2022; 20(10):2001-2012. PubMed ID: 35450527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the Chinese version of the questionnaire of olfactory disorders (QOD) when used with patients having olfactory dysfunction.
    Yang D; Wang J; Ni D; Liu J; Wang X
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3255-61. PubMed ID: 26724948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Chronic Kidney Disease on Olfactory Function: A Case-Control Study.
    Yusuf T; Raji YR; Daniel A; Bamidele OT; Fasunla AJ; Lasisi OA
    Ear Nose Throat J; 2023 Mar; 102(3):188-192. PubMed ID: 33617293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression Symptoms and Olfactory-related Quality of Life.
    Liu DT; Prem B; Sharma G; Kaiser J; Besser G; Mueller CA
    Laryngoscope; 2022 Sep; 132(9):1829-1834. PubMed ID: 35353380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Miryan M; Bagherniya M; Sahebkar A; Soleimani D; Rouhani MH; Iraj B; Askari G
    Trials; 2020 Dec; 21(1):1027. PubMed ID: 33334357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.